X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - ZACKS.COM - All Stories - 16/Sep 17:21

Incyte Announces Promising New Data on Oncology Candidate at ESMO

INCY's INCB123667 data show the candidate's potential as a differentiated treatment option for cancers with increased cyclin E1 activity, amplification and/or overexpression in cells predictive of CDK2 dependency.

Articles similaires

Sorry! Image not available at this time

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

news.medical.net - 14/Sep 10:33

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from...

Sorry! Image not available at this time

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

news.medical.net - 14/Sep 10:33

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from...

Sorry! Image not available at this time

Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress

healthtechzone.com - 08/Sep 22:05

Sorry! Image not available at this time

Research confirms safety of breastfeeding for breast cancer survivors with BRCA mutations

news.medical.net - 09/Sep 19:50

According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer,...

Sorry! Image not available at this time

Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors

healthtechzone.com - 14/Sep 07:00

Sorry! Image not available at this time

Belong.Life Announces Publication of Abstract at ESMO Congress 2024

healthtechzone.com - 09/Sep 13:00

Sorry! Image not available at this time

Cytovation to present safety and efficacy data from CICILIA phase I/IIa clinical trial evaluating CY─101 in solid tumors

pharmabiz.com - 17/Sep 01:13

Cytovation ASA, a clinical stage oncology company focused on the development of its first─in─class bifunctional immunotherapy CY─101 (CyPep─1)...

Sorry! Image not available at this time

BostonGene Announces Acceptance of Three Abstracts for Presentation at ESMO Congress 2024

healthtechzone.com - 13/Sep 10:00

Sorry! Image not available at this time

BostonGene Announces Acceptance of Three Abstracts for Presentation at ESMO Congress 2024

healthtechzone.com - 13/Sep 10:00

Sorry! Image not available at this time

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

news.medical.net - 13/Sep 16:35

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination...

Les derniers communiqués